Home Tags PhysIQ
PhysIQ, the Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), in conjunction with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), announced the launch of an initiative to deploy physIQ’s platform to collect and analyze wearable sensor data to better understand […]
PhysIQ, a company dedicated to enabling proactive care delivery models through its highly scalable cloud-based platform for personalized physiology analytics, announced two new patent allowances by the US Patent & Trademark Office on its core analytics in digital medicine. These analytics help power PhysIQ’s machine learning and artificial intelligence approach to providing a platform for […]
PhysIQ, a company known for applying Artificial Intelligence (AI) in wearable sensor data, received FDA 510(k) clearance for an algorithm facilitating cloud-based analysis of patients’ continuous ambulatory respiration rates. This regulatory clearance adds to the company’s expanding portfolio of FDA-cleared cloud-based analytics, which also include QRS detection, heart rate, heart rate variability, atrial fibrillation detection, […]
Omron Healthcare has partnered with physIQ to integrate Omron’s wearable blood pressure monitor, HeartGuide, into physIQ’s pinpointIQ® platform to monitor at-risk patients in an outpatient setting. The partnership is aimed at generating actionable clinical information for at-risk patients in an outpatient environment by leveraging the complementary technologies of each company. Omron is the global leader […]
Netherlands-Based Haga Teaching Hospital Partners with physIQ and VitalConnect for Continuous Monitoring of Cancer...
Netherlands-based Haga Teaching Hospital is teaming up with physIQ, and VitalConnect to conduct a study on how wearable biosensors and artificial intelligence (AI) can add to the care for cancer patients undergoing treatment. The study, funded by Janssen Pharmaceuticals, is looking to see how wearable technology can provide early clinical indication of adverse events sometimes […]